Trial Profile
Study investigating residual platelet recovery and rate of high on-treatment platelet recovery in myocardial infarction (MI) patients receiving prasugrel or ticagrelor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 14 Dec 2015 New trial record